In vitro activities of linezolid, meropenem, and quinupristin-dalfopristinagainst group C and G streptococci, including vancomycin-tolerant isolates

Authors
Zaoutis, T Moore, LS Furness, K Klein, JD
Citation
T. Zaoutis et al., In vitro activities of linezolid, meropenem, and quinupristin-dalfopristinagainst group C and G streptococci, including vancomycin-tolerant isolates, ANTIM AG CH, 45(7), 2001, pp. 1952-1954
Citations number
22
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
45
Issue
7
Year of publication
2001
Pages
1952 - 1954
Database
ISI
SICI code
0066-4804(200107)45:7<1952:IVAOLM>2.0.ZU;2-6
Abstract
The in vitro activities of meropenem, linezolid, quinupristin dalfopristin, vancomycin, and penicillin against 130 clinical isolates of group C and G streptococci, including vancomycin-tolerant isolates, were evaluated. Merop enem, linezolid, quinupristin-dalfopristin, vancomycin, and penicillin MICs at which 90% of the isolates were inhibited were 0.06, 2.0, 0.25, 0.5, and less than or equal to0.016 mug/ml, respectively. Meropenem, linezolid, qui nupristin-dalfopristin, and penicillin were active against group C and G st reptococci, including vancomycin-resistant strains.